Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Change in Cash (2010 - 2026)

Emergent BioSolutions (EBS) posted Change in Cash of -$20.6 million for Q2 2026, up 56.72% on a QoQ basis from -$47.6 million in Q1 2026, and down 117.43% year-over-year from $118.2 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Change in Cash (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Change in Cash for 17 years, with the latest figure at -$20.6 million in Q2 2026.

  • On a quarterly basis, Change in Cash fell 117.43% year-over-year to -$20.6 million in Q2 2026; TTM through Jun 2026 was -$130.1 million, a 165.05% decrease from a year earlier, with the FY2025 full-year figure at $103.5 million, up 1796.72% from the prior year.
  • Change in Cash was -$20.6 million for Q2 2026 at Emergent BioSolutions, up from -$47.6 million in the prior quarter.
  • The five-year high for Change in Cash was $401.6 million in Q4 2022, with the low at -$344.2 million in Q2 2023.
  • Average Change in Cash over 5 years is -$24.2 million, with a median of -$27.2 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Change in Cash tumbled 342.99% in 2023, then surged 10775.0% in 2024.
  • Over 5 years, Change in Cash stood at $401.6 million in 2022, then slumped by 94.05% to $23.9 million in 2023, then slumped by 312.55% to -$50.8 million in 2024, then rose by 21.06% to -$40.1 million in 2025, then jumped by 48.63% to -$20.6 million in 2026.
  • The last three Change in Cash figures came in at -$20.6 million (Q2 2026), -$47.6 million (Q1 2026), and -$40.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn -1.27 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -2.82 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 739.00 Mn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -727.00 Mn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn -861.00 Mn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 929.89 Mn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 427.25 Mn
9 Revolution Medicines 41.30 Bn 41.30 Bn - 374.50 Mn
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -20.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.60 Mn
Mar 31, 2026 -47.60 Mn
Dec 31, 2025 -40.10 Mn
Sep 30, 2025 -21.80 Mn
Jun 30, 2025 118.20 Mn
Mar 31, 2025 47.20 Mn
Dec 31, 2024 -50.80 Mn
Sep 30, 2024 85.40 Mn
Jun 30, 2024 -8.00 Mn
Mar 31, 2024 -32.70 Mn
Dec 31, 2023 23.90 Mn
Sep 30, 2023 -800,000.00
Jun 30, 2023 -344.20 Mn
Mar 31, 2023 -209.80 Mn
Dec 31, 2022 401.60 Mn
Sep 30, 2022 -117.30 Mn
Jun 30, 2022 -77.70 Mn
Mar 31, 2022 -140.30 Mn
Dec 31, 2021 172.30 Mn
Sep 30, 2021 -43.70 Mn
API Access

Emergent BioSolutions Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=EBS&period=max&api_key=YOUR_API_KEY